Agoracom: Small Cap Investment - Zenith Epigenetics - Re: Trodelvy - development history and valuations along the way

...We Welcome You to the Zenith Epigenetics Hub withIn The AGORACOM COMMUNITY!

Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials

Reply New Message

Prev Message Back To Forum Threaded View Next Message

bionug

Rank: Mail Room [?]

Points: 24 [?]

Votes: 1 Score: 4.0 [?]

Your Vote:

Please Log In to Vote

Did you know? You can earn activity points by filling your profile with information about yourself (what city you live in, your favorite team, blogs etc.)

Re: Trodelvy - development history and valuations along the way

in response to

Trodelvy - development history and valuations along the way

Payzone

posted on Jul 04, 2023 01:51PM

Doesn't Zenith already has a licensing agreement with NewSoara for a upfront payment of 3.5M?

https://www.zenithepigenetics.com/newsroom/news-releases.html?article=52

3 Recommendations

Reply New Message

Prev Message Back To Forum Threaded View Next Message

Please to post a reply